Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Variation in Colonoscopy Performance Measures According to Procedure Indication.

Mangas-Sanjuan C, Santana E, Cubiella J, Rodríguez-Camacho E, Seoane A, Alvarez-Gonzalez MA, Suárez A, Álvarez-García V, González N, Luè A, Cid-Gomez L, Ponce M, Bujanda L, Portillo I, Pellisé M, Díez-Redondo P, Herráiz M, Ono A, Pizarro Á, Zapater P, Jover R; QUALISCOPIA Study Investigators.

Clin Gastroenterol Hepatol. 2019 Aug 22. pii: S1542-3565(19)30910-3. doi: 10.1016/j.cgh.2019.08.035. [Epub ahead of print]

PMID:
31446179
2.

Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.

Juanola O, Ferrusquía-Acosta J, García-Villalba R, Zapater P, Magaz M, Marín A, Olivas P, Baiges A, Bellot P, Turon F, Hernández-Gea V, González-Navajas JM, Tomás-Barberán FA, García-Pagán JC, Francés R.

FASEB J. 2019 Oct;33(10):11595-11605. doi: 10.1096/fj.201901327R. Epub 2019 Jul 25.

PMID:
31345057
3.

Actual Anti-TNF Trough Levels Relate to Serum IL-10 in Drug-Responding Patients With Crohn's Disease.

Zapater P, Almenara S, Gutiérrez A, Sempere L, García M, Laveda R, Martínez A, Scharl M, Cameo JI, Linares R, González-Navajas JM, Wiest R, Rogler G, Francés R.

Inflamm Bowel Dis. 2019 Jul 17;25(8):1357-1366. doi: 10.1093/ibd/izz012.

PMID:
30776076
4.

Bacterial DNA translocation contributes to systemic inflammation and to minor changes in the clinical outcome of liver transplantation.

Rodríguez-Laiz GP, Zapater P, Melgar P, Alcázar C, Franco M, Giménez P, Pascual S, Bellot P, Palazón JM, Rodríguez M, Carnicer F, Más-Serrano P, González-Navajas JM, Gómez L, Such J, Lluís F, Francés R; Liver Transplantation Group.

Sci Rep. 2019 Jan 29;9(1):835. doi: 10.1038/s41598-018-36904-0.

5.

Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short-Chain Fatty Acids in Experimental Cirrhosis.

Juanola O, Piñero P, Gómez-Hurtado I, Caparrós E, García-Villalba R, Marín A, Zapater P, Tarín F, González-Navajas JM, Tomás-Barberán FA, Francés R.

Hepatol Commun. 2018 Oct 22;2(12):1610-1623. doi: 10.1002/hep4.1268. eCollection 2018 Dec.

6.

Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.

Murcia O, Juárez M, Rodríguez-Soler M, Hernández-Illán E, Giner-Calabuig M, Alustiza M, Egoavil C, Castillejo A, Alenda C, Barberá V, Mangas-Sanjuan C, Yuste A, Bujanda L, Clofent J, Andreu M, Castells A, Llor X, Zapater P, Jover R.

PLoS One. 2018 Sep 6;13(9):e0203051. doi: 10.1371/journal.pone.0203051. eCollection 2018.

7.

AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.

Martínez-Cardona C, Lozano-Ruiz B, Bachiller V, Peiró G, Algaba-Chueca F, Gómez-Hurtado I, Such J, Zapater P, Francés R, González-Navajas JM.

Int J Cancer. 2018 Dec 1;143(11):2997-3007. doi: 10.1002/ijc.31827. Epub 2018 Oct 9.

8.

Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox.

Mangas-Sanjuan C, Zapater P, Cubiella J, Murcia Ó, Bujanda L, Hernández V, Martínez-Ares D, Pellisé M, Seoane A, Lanas Á, Nicolás-Pérez D, Herreros-de-Tejada A, Chaparro M, Cacho G, Fernández-Díez S, Marín-Gabriel JC, Quintero E, Castells A, Jover R; COLONPREV study investigators.

United European Gastroenterol J. 2018 May;6(4):622-629. doi: 10.1177/2050640617745458. Epub 2017 Nov 24.

9.

Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.

Gimenez P, Garcia-Martinez I, Francés R, Gonzalez-Navajas JM, Mauri M, Alfayate R, Almenara S, Miralles C, Palazon JM, Carnicer F, Pascual S, Such J, Horga JF, Zapater P.

Liver Int. 2018 Dec;38(12):2219-2227. doi: 10.1111/liv.13890. Epub 2018 Jun 19.

10.

Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765.

Gómez-Hurtado I, Zapater P, Portune K, Juanola O, Fernández-Iglesias A, González-Navajas JM, Gracia-Sancho J, Sanz Y, Francés R.

Eur J Nutr. 2019 Jun;58(4):1647-1658. doi: 10.1007/s00394-018-1709-y. Epub 2018 May 10.

PMID:
29748815
11.

Genetic studies and alcoholic liver disease.

Zapater P.

Rev Clin Esp. 2018 May;218(4):190-191. doi: 10.1016/j.rce.2018.03.007. English, Spanish. No abstract available.

PMID:
29709216
12.

Determinants of Severity in Acute Pancreatitis: A Nation-wide Multicenter Prospective Cohort Study.

Sternby H, Bolado F, Canaval-Zuleta HJ, Marra-López C, Hernando-Alonso AI, Del-Val-Antoñana A, García-Rayado G, Rivera-Irigoin R, Grau-García FJ, Oms L, Millastre-Bocos J, Pascual-Moreno I, Martínez-Ares D, Rodríguez-Oballe JA, López-Serrano A, Ruiz-Rebollo ML, Viejo-Almanzor A, González-de-la-Higuera B, Orive-Calzada A, Gómez-Anta I, Pamies-Guilabert J, Fernández-Gutiérrez-Del-Álamo F, Iranzo-González-Cruz I, Pérez-Muñante ME, Esteba MD, Pardillos-Tomé A, Zapater P, de-Madaria E.

Ann Surg. 2019 Aug;270(2):348-355. doi: 10.1097/SLA.0000000000002766.

PMID:
29672416
13.

β2‑adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease: Liver cirrhosis and osteoarthritis.

Roca R, Esteban P, Zapater P, Inda MD, Conte AL, Gómez-Escolar L, Martínez H, Horga JF, Palazon JM, Peiró AM.

Mol Med Rep. 2018 Jun;17(6):7987-7995. doi: 10.3892/mmr.2018.8820. Epub 2018 Mar 29.

PMID:
29620176
14.

Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort.

Ranieri L, Contero C, Peral ML, Calabuig I, Zapater P, Andres M.

Arthritis Res Ther. 2018 Mar 22;20(1):53. doi: 10.1186/s13075-018-1559-2.

15.

Fluid resuscitation with lactated Ringer's solution vs normal saline in acute pancreatitis: A triple-blind, randomized, controlled trial.

de-Madaria E, Herrera-Marante I, González-Camacho V, Bonjoch L, Quesada-Vázquez N, Almenta-Saavedra I, Miralles-Maciá C, Acevedo-Piedra NG, Roger-Ibáñez M, Sánchez-Marin C, Osuna-Ligero R, Gracia Á, Llorens P, Zapater P, Singh VK, Moreu-Martín R, Closa D.

United European Gastroenterol J. 2018 Feb;6(1):63-72. doi: 10.1177/2050640617707864. Epub 2017 Apr 27.

16.

KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.

Juárez M, Egoavil C, Rodríguez-Soler M, Hernández-Illán E, Guarinos C, García-Martínez A, Alenda C, Giner-Calabuig M, Murcia O, Mangas C, Payá A, Aparicio JR, Ruiz FA, Martínez J, Casellas JA, Soto JL, Zapater P, Jover R.

PLoS One. 2017 Sep 27;12(9):e0184937. doi: 10.1371/journal.pone.0184937. eCollection 2017.

17.

IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA.

Piñero P, Juanola O, Gutiérrez A, Zapater P, Giménez P, Steinert A, Sempere L, González-Navajas JM, Niess JH, Francés R.

J Mol Med (Berl). 2017 Nov;95(11):1227-1236. doi: 10.1007/s00109-017-1585-6. Epub 2017 Sep 6.

PMID:
28879509
18.

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.

Gómez-Hurtado I, Gimenez P, García I, Zapater P, Francés R, González-Navajas JM, Manichanh C, Ramos JM, Bellot P, Guarner F, Such J.

Liver Int. 2018 Feb;38(2):295-302. doi: 10.1111/liv.13551. Epub 2017 Sep 13.

PMID:
28834270
19.

An international multicenter study of early intravenous fluid administration and outcome in acute pancreatitis.

Singh VK, Gardner TB, Papachristou GI, Rey-Riveiro M, Faghih M, Koutroumpakis E, Afghani E, Acevedo-Piedra NG, Seth N, Sinha A, Quesada-Vázquez N, Moya-Hoyo N, Sánchez-Marin C, Martínez J, Lluís F, Whitcomb DC, Zapater P, de-Madaria E.

United European Gastroenterol J. 2017 Jun;5(4):491-498. doi: 10.1177/2050640616671077. Epub 2016 Sep 20.

20.

Response to "Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-mixed Triglyceride Breath Test versus Fecal Elastase: Methodological issues".

de-Madaria E, González-Sánchez V, Picó A, Zapater P.

Pancreatology. 2017 Sep - Oct;17(5):648. doi: 10.1016/j.pan.2017.05.386. Epub 2017 May 22. No abstract available.

PMID:
28566224
21.

Toll-like receptor polymorphisms compromise the inflammatory response against bacterial antigen translocation in cirrhosis.

Piñero P, Juanola O, Caparrós E, Zapater P, Giménez P, González-Navajas JM, Such J, Francés R.

Sci Rep. 2017 Apr 18;7:46425. doi: 10.1038/srep46425.

22.

Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.

Egoavil C, Juárez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Piñol V, Rodríguez Moranta F, Nicolás-Pérez D, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Zapater P, Jover R.

Gastroenterology. 2017 Jul;153(1):106-112.e2. doi: 10.1053/j.gastro.2017.04.003. Epub 2017 Apr 9.

PMID:
28400194
23.

The expression and activation of the AIM2 inflammasome correlates with inflammation and disease severity in patients with acute pancreatitis.

Algaba-Chueca F, de-Madaria E, Lozano-Ruiz B, Martínez-Cardona C, Quesada-Vázquez N, Bachiller V, Tarín F, Such J, Francés R, Zapater P, González-Navajas JM.

Pancreatology. 2017 May - Jun;17(3):364-371. doi: 10.1016/j.pan.2017.03.006. Epub 2017 Mar 18.

PMID:
28342645
24.

aLicante sUrgical Community Emergencies New Tool for the enUmeration of Morbidities: a simplified auditing tool for community-acquired gastrointestinal surgical emergencies.

Villodre C, Rebasa P, Estrada JL, Zaragoza C, Zapater P, Mena L, Lluís F; Residents of General and Digestive Surgery, Hospital General Universitario de Alicante.

Am J Surg. 2016 Nov;212(5):917-926. doi: 10.1016/j.amjsurg.2016.01.041. Epub 2016 May 7.

PMID:
27392752
25.

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy.

Moratalla A, Ampuero J, Bellot P, Gallego-Durán R, Zapater P, Roger M, Figueruela B, Martínez-Moreno B, González-Navajas JM, Such J, Romero-Gómez M, Francés R.

Liver Int. 2017 Feb;37(2):212-223. doi: 10.1111/liv.13200. Epub 2016 Jul 29.

PMID:
27388776
26.

The use of β-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis.

Herrera I, Pascual S, Zapater P, Carnicer F, Bellot P, María Palazón J.

Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1194-7. doi: 10.1097/MEG.0000000000000677.

PMID:
27294486
27.

Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis.

Juanola O, Gómez-Hurtado I, Zapater P, Moratalla A, Caparrós E, Piñero P, González-Navajas JM, Giménez P, Such J, Francés R.

Liver Int. 2016 Dec;36(12):1811-1820. doi: 10.1111/liv.13172. Epub 2016 Jun 21.

PMID:
27214392
28.

Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis.

Caro E, Francés R, Zapater P, Pascual S, Bellot P, Such J.

Liver Int. 2016 Oct;36(10):1473-80. doi: 10.1111/liv.13118. Epub 2016 Apr 28.

PMID:
26991936
29.

Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn's Disease.

Gutiérrez A, Zapater P, Juanola O, Sempere L, García M, Laveda R, Martínez A, Scharl M, González-Navajas JM, Such J, Wiest R, Rogler G, Francés R.

Am J Gastroenterol. 2016 Apr;111(4):529-40. doi: 10.1038/ajg.2016.8. Epub 2016 Feb 23.

30.

Endoscopist characteristics that influence the quality of colonoscopy.

Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E; COLONPREV Study Investigators.

Endoscopy. 2016 Mar;48(3):241-7. doi: 10.1055/s-0042-100185. Epub 2016 Feb 4.

PMID:
26845473
31.

Variations of pharmacokinetics of drugs in patients with cirrhosis.

Pena MA, Horga JF, Zapater P.

Expert Rev Clin Pharmacol. 2016;9(3):441-58. doi: 10.1586/17512433.2016.1135733. Epub 2016 Jan 15. Review.

PMID:
26696448
32.

Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosis.

Zapater P, González-Navajas JM, Such J, Francés R.

World J Gastroenterol. 2015 Nov 7;21(41):11493-501. doi: 10.3748/wjg.v21.i41.11493. Review.

33.

A Case of Toxic Epidermal Necrolysis Secondary to Acetaminophen in a Child.

Pena MÁ, Pérez S, Zazo MC, Alcalá PJ, Cuello JD, Zapater P, Reig R.

Curr Drug Saf. 2016;11(1):99-101.

PMID:
26391426
34.

Perineal body anatomy seen by three-dimensional endovaginal ultrasound of asymptomatic nulliparae.

Santoro GA, Shobeiri SA, Petros PP, Zapater P, Wieczorek AP.

Colorectal Dis. 2016 Apr;18(4):400-9. doi: 10.1111/codi.13119.

PMID:
26382090
35.

Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis.

Moratalla A, Caparrós E, Juanola O, Portune K, Puig-Kröger A, Estrada-Capetillo L, Bellot P, Gómez-Hurtado I, Piñero P, Zapater P, González-Navajas JM, Such J, Sanz Y, Francés R.

J Hepatol. 2016 Jan;64(1):135-45. doi: 10.1016/j.jhep.2015.08.020. Epub 2015 Aug 31.

PMID:
26334579
36.

Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis.

Ramos JM, Vidal I, Bellot P, Gómez-Hurtado I, Zapater P, Such J.

Gut. 2016 Jan;65(1):182-3. doi: 10.1136/gutjnl-2015-309421. Epub 2015 Apr 1. No abstract available.

PMID:
25832107
37.

Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis.

Moratalla A, Gómez-Hurtado I, Moya-Pérez Á, Zapater P, Peiró G, González-Navajas JM, Gómez Del Pulgar EM, Such J, Sanz Y, Francés R.

Eur J Nutr. 2016 Feb;55(1):197-206. doi: 10.1007/s00394-015-0837-x. Epub 2015 Feb 6.

PMID:
25657013
38.

Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.

Juanola O, Moratalla A, Gutiérrez A, Sempere L, Zapater P, Giménez P, Almenta I, Peiró G, González-Navajas JM, Such JF, Francés R.

J Gastroenterol. 2015 Jul;50(7):758-68. doi: 10.1007/s00535-014-1020-5. Epub 2014 Dec 11.

PMID:
25500977
39.

Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.

Horga A, Pitceathly RD, Blake JC, Woodward CE, Zapater P, Fratter C, Mudanohwo EE, Plant GT, Houlden H, Sweeney MG, Hanna MG, Reilly MM.

Brain. 2014 Dec;137(Pt 12):3200-12. doi: 10.1093/brain/awu279. Epub 2014 Oct 3.

40.

Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice.

Bertin S, Lozano-Ruiz B, Bachiller V, García-Martínez I, Herdman S, Zapater P, Francés R, Such J, Lee J, Raz E, González-Navajas JM.

Mucosal Immunol. 2015 May;8(3):505-15. doi: 10.1038/mi.2014.84. Epub 2014 Sep 17.

41.

Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis.

Lozano-Ruiz B, Bachiller V, García-Martínez I, Zapater P, Gómez-Hurtado I, Moratalla A, Giménez P, Bellot P, Francés R, Such J, González-Navajas JM.

J Hepatol. 2015 Jan;62(1):64-71. doi: 10.1016/j.jhep.2014.08.027. Epub 2014 Aug 27.

PMID:
25173967
42.

Acute effects of dipyrone on renal function in patients with cirrhosis: a randomized controlled trial.

Zapater P, Llanos L, Barquero C, Bellot P, Pascual S, Carnicer F, Palazón JM, Gimenez P, Esteban A, Llorca L, Francés R, Horga JF, Such J.

Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):257-63. doi: 10.1111/bcpt.12312. Epub 2014 Oct 8.

43.

Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis.

Garcia-Martinez I, Francés R, Zapater P, Giménez P, Gómez-Hurtado I, Moratalla A, Lozano-Ruiz B, Bellot P, González-Navajas JM, Such J.

J Gastroenterol Hepatol. 2015 Jan;30(1):147-54. doi: 10.1111/jgh.12667.

PMID:
25039465
44.

Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis.

Gómez-Hurtado I, Moratalla A, Moya-Pérez Á, Peiró G, Zapater P, González-Navajas JM, Giménez P, Such J, Sanz Y, Francés R.

J Hepatol. 2014 Oct;61(4):799-808. doi: 10.1016/j.jhep.2014.05.031. Epub 2014 Jun 2.

PMID:
24882049
45.

Bacterial DNA translocation holds increased insulin resistance and systemic inflammatory levels in morbid obese patients.

Ortiz S, Zapater P, Estrada JL, Enriquez P, Rey M, Abad A, Such J, Lluis F, Francés R.

J Clin Endocrinol Metab. 2014 Jul;99(7):2575-83. doi: 10.1210/jc.2013-4483. Epub 2014 Apr 15.

PMID:
24735424
46.

Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis.

Moratalla A, Gómez-Hurtado I, Santacruz A, Moya Á, Peiró G, Zapater P, González-Navajas JM, Giménez P, Such J, Sanz Y, Francés R.

Liver Int. 2014 Jul;34(6):850-8. doi: 10.1111/liv.12380. Epub 2013 Nov 24.

PMID:
24267920
47.

Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.

Llorens P, Miró Ò, Herrero P, Martín-Sánchez FJ, Jacob J, Valero A, Alonso H, Pérez-Durá MJ, Noval A, Gil-Román JJ, Zapater P, Llanos L, Gil V, Perelló R.

Emerg Med J. 2014 Sep;31(9):706-13. doi: 10.1136/emermed-2013-202526. Epub 2013 Jun 22.

PMID:
23793945
48.

Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.

Gutiérrez A, Scharl M, Sempere L, Holler E, Zapater P, Almenta I, González-Navajas JM, Such J, Wiest R, Rogler G, Francés R.

Gut. 2014 Feb;63(2):272-80. doi: 10.1136/gutjnl-2012-303557. Epub 2013 Feb 1.

49.

Risk of cancer in cases of suspected lynch syndrome without germline mutation.

Rodríguez-Soler M, Pérez-Carbonell L, Guarinos C, Zapater P, Castillejo A, Barberá VM, Juárez M, Bessa X, Xicola RM, Clofent J, Bujanda L, Balaguer F, Reñé JM, de-Castro L, Marín-Gabriel JC, Lanas A, Cubiella J, Nicolás-Pérez D, Brea-Fernández A, Castellví-Bel S, Alenda C, Ruiz-Ponte C, Carracedo A, Castells A, Andreu M, Llor X, Soto JL, Payá A, Jover R.

Gastroenterology. 2013 May;144(5):926-932.e1; quiz e13-4. doi: 10.1053/j.gastro.2013.01.044. Epub 2013 Jan 24.

PMID:
23354017
50.

Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study.

Bellot P, Welker MW, Soriano G, von Schaewen M, Appenrodt B, Wiest R, Whittaker S, Tzonev R, Handshiev S, Verslype C, Moench C, Zeuzem S, Sauerbruch T, Guarner C, Schott E, Johnson N, Petrov A, Katzarov K, Nevens F, Zapater P, Such J.

J Hepatol. 2013 May;58(5):922-7. doi: 10.1016/j.jhep.2012.12.020. Epub 2013 Jan 11.

PMID:
23318604

Supplemental Content

Loading ...
Support Center